BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33742980)

  • 21. Treatment of recurrent malignant sacrococcygeal germ cell tumors: analysis of 22 patients registered in the German protocols MAKEI 83/86, 89, and 96.
    Schneider DT; Wessalowski R; Calaminus G; Pape H; Bamberg M; Engert J; Waag K; Gadner H; Göbel U
    J Clin Oncol; 2001 Apr; 19(7):1951-60. PubMed ID: 11283127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvage chemotherapy after failure of first-line chemotherapy in patients with metastatic testicular cancer.
    Kollmannsberger C; Bokemeyer C
    Curr Opin Support Palliat Care; 2008 Sep; 2(3):167-72. PubMed ID: 18685416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Salvage treatment in germ cell tumors : high-dose chemotherapy and the impact of prognostic factors].
    Lorch A; Oechsle K; Bokemeyer C; Beyer J
    Urologe A; 2009 Apr; 48(4):364-71. PubMed ID: 19255738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors.
    Bokemeyer C
    Oncology; 1998; 55(3):177-88. PubMed ID: 9560052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High dose chemotherapy as salvage treatment for unresectable late relapse germ cell tumors.
    Lorch A; Rick O; Wündisch T; Hartmann JT; Bokemeyer C; Beyer J
    J Urol; 2010 Jul; 184(1):168-73. PubMed ID: 20483152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current Status of Stem Cell Transplant in Treatment of Testicular Germ Cell Tumors.
    King J; Adra N
    Curr Oncol Rep; 2022 Mar; 24(3):303-310. PubMed ID: 35113353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
    Einhorn LH; Williams SD; Chamness A; Brames MJ; Perkins SM; Abonour R
    N Engl J Med; 2007 Jul; 357(4):340-8. PubMed ID: 17652649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of testicular germ cell tumors relapse].
    Carbonnaux M; Vinceneux A; Peyrat P; Fléchon A
    Bull Cancer; 2020 Sep; 107(9):912-924. PubMed ID: 32653158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late relapsing germ cell tumors with elevated tumor markers.
    Che Y; Lusch A; Winter C; Große Siemer R; Buddensieck C; Albers P; Hiester A
    World J Urol; 2022 Feb; 40(2):363-371. PubMed ID: 34518930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postchemotherapy Residual Tumor Resection in Patients with Elevated Tumor Markers.
    Che Y; Buddensieck C; Albers P; Lusch A; Winter C; Siemer RG; Hiester A
    J Urol; 2022 Mar; 207(3):617-626. PubMed ID: 34694152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how.
    Lorch A; Beyer J
    World J Urol; 2017 Aug; 35(8):1177-1184. PubMed ID: 27678272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapeutic treatment of germ cell tumors: standard of care and recent developments.
    Oing C; Seidel C; von Amsberg G; Oechsle K; Bokemeyer C
    Expert Opin Pharmacother; 2016; 17(4):545-60. PubMed ID: 26630452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of recurrent testicular germ cell tumors.
    Sonpavde G; Hutson TE; Roth BJ
    Oncologist; 2007 Jan; 12(1):51-61. PubMed ID: 17227900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P; Haas RJ; Göbel U; Calaminus G
    Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
    Pico JL; Fadel E; Ibrahim A; Bourhis JH; Droz JP
    Bull Cancer; 1995; 82 Suppl 1():56s-60s. PubMed ID: 7542945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salvage therapy in recurrent testicular cancer.
    Saxman S
    Semin Oncol; 1992 Apr; 19(2):143-7. PubMed ID: 1372756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumor.
    Nason GJ; Jewett MAS; Bostrom PJ; Goldberg H; Hansen AR; Bedard PL; Sturgeon J; Warde P; Chung P; Anson-Cartwright L; Sweet J; Atenafu EG; O'Malley M; Hamilton RJ
    Eur Urol Oncol; 2021 Apr; 4(2):289-296. PubMed ID: 32907779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.